Dr. Wenjun Mao is a distinguished medical professional with a dual role as an Associate Professor and Master's Supervisor at Nanjing Medical University and an Associate Chief Physician in the Department of Thoracic Surgery at the Affiliated Wuxi People's Hospital of Nanjing Medical University. In 2023, he was selected as one of the most active expert scholars in thoracic surgery research in China. He is a member of The Scientific Research Honor Society (Sigma Xi), a Fellow of the Royal Society of Medicine (RSM), a member of The Society of Thoracic Surgeons (STS), and a member of the International Society for Heart and Lung Transplantation (ISHLT). His expertise spans lung cancer, tumor extracellular vesicles, and lung transplantation. Dr. Mao has served in various editorial capacities for prestigious journals and is actively involved in research encompassing immunotherapy, tumor biology, and bioinformatics. With a robust publication record in SCI-indexed journals, he contributes pivotal insights into advancing cancer diagnosis and treatments. Meanwhile, Dr. Mao is an accomplished academic editor in the scientific community. He serves as an Associate Editor for journals such as "iMeta" and "Technology in Cancer Research & Treatment," and is an editorial board member for numerous publications, including "BMC Cancer", "Cancer Drug Resistance", "Journal of Genetics and Genomics", etc.